APA (7th ed.) Citation

A, H., C, G., R, L., ML, F., JD, G., & CJ, B. (2022). Glatiramer Acetate Complexed with CpG as Intratumoral Immunotherapy in Combination with Anti-PD-1. Molecular pharmaceutics, 19(11), 4357. https://doi.org/10.1021/acs.molpharmaceut.2c00730

Chicago Style (17th ed.) Citation

A, Huang, Groer C, Lu R, Forrest ML, Griffin JD, and Berkland CJ. "Glatiramer Acetate Complexed with CpG as Intratumoral Immunotherapy in Combination with Anti-PD-1." Molecular Pharmaceutics 19, no. 11 (2022): 4357. https://doi.org/10.1021/acs.molpharmaceut.2c00730.

MLA (9th ed.) Citation

A, Huang, et al. "Glatiramer Acetate Complexed with CpG as Intratumoral Immunotherapy in Combination with Anti-PD-1." Molecular Pharmaceutics, vol. 19, no. 11, 2022, p. 4357, https://doi.org/10.1021/acs.molpharmaceut.2c00730.